Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Nevirapine XR in HIV-1
NCT00819052Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2008
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Boehringer Ingelheim. Started Dec 2008; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00819052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819052.